Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine vs Hydralazine for Severe Hypertension in Pregnancy
NCT04435210Completed
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nifedipine in hypertensive disorders of pregnancy (HDP) (2 arms). Primary endpoint: Number of drug doses at 24 hours. Started Aug 2018; status: completed.
02
Drugs
nifedipine
03
Conditions
hypertensive disorders of pregnancy (HDP)
Beyond the preview
Go deeper on NCT04435210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435210.